Skip to content
by Legal Desire
19 February 2025

Latham & Watkins Advises Arcus Biosciences in US$150 Million Offering of Common Stock

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Mark Roeder Lead Latham & Watkins LLP Partner corporate Bay Area
John Williams Lead Latham & Watkins LLP Partner corporate Bay Area
Caitlin Nguyen Latham & Watkins LLP Associate corporate Not stated
Chelsi DeTurk Latham & Watkins LLP Associate corporate Not stated
Kelsey MacKinnon Latham & Watkins LLP Associate corporate Not stated
Christopher Hazuka Latham & Watkins LLP Partner intellectual property San Diego/Bay Area
Robert Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Elizabeth Richards Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Evan Miller Latham & Watkins LLP Associate regulatory Not stated
Kirt Switzer Latham & Watkins LLP Partner tax Bay Area
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Alphonse Simon Latham & Watkins LLP Associate tax Not stated
Jay Metz Latham & Watkins LLP Partner compensation and benefits Bay Area

Stated terms

Stated value
USD 150m (US$150 million)
What the figure measures
Issue size
Client
Arcus Biosciences, Inc.Issuer
Counterparties
Not stated